Online edition of India's National Newspaper
Wednesday, Mar 31, 2004

About Us
Contact Us
Business
News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts:
Classifieds | Employment | Obituary |

Business - Briefly Printer Friendly Page   Send this Article to a Friend

Shreya Life Sciences' plans

HYDERABAD: The Rs. 180 crore Mumbai based Shreya Life Sciences has chalked out ambitious plans to achieve a turnover of Rs. 200 crores next year and a quantum jump to Rs. 500 crores by March 2006. They hope to achieve this using the route of acquisitions and line extension, according to Amitava Sengupta, National Head of Sales. Addressing a press conference here on Tuesday, he said the company had acquired the pharmaceutical division of Rallis India (a Tata Enterprise) in 2001, and Indore based Ethico and Plethico six months ago. Its new Pune facility would be ready by mid-2005 to produce human insulin and novel drug delivery, and hepatitis B vaccine. It is now strong in gastro intestinal care (GI Care), pain management and nutritional range, with gastro drugs accounting for 33 per cent of revenues. These were also the segments in which they were looking for acquisitions, he said. The company also launched its latest offering `Tadalafil' here on Tuesday. — Our Special Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts:
Classifieds | Employment | Obituary | Updates: Breaking News |


News Update


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright 2004, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu